LSE Capital Limited (PSX: LSECL) has announced that its Board of Directors approved a Joint Venture (JV) arrangement with LABLINK Enterprises for pre-qualification and bidding on a project in Sindh.
LABLINK Enterprises is a sole proprietorship engaged in the import, distribution, and supply of medical, healthcare, and surgical products, representing multinational principals including NIPRO and Baxter.
Read the full story on the original publisher’s website.
Open original article